йڷÎÑ×Ñо¿ÏÔʾ£ºOÐÍѪ¸ÐȾÂÊÏà¶ÔµÍ£¬AÐÍѪ¸ÐȾÂÊÏà¶ÔÆ«¸ß

À´Ô´£º ÅìÅÈÐÂÎÅ 2020-03-18

йڲ¡¶¾ OÐÍѪ¸ÐȾÂÊÏà¶ÔµÍ.jpg


    йڷÎÑ×»¼ÕßÁÙ´²¹Û²ì±íÃ÷£¬ÀÏÄêÈË¡¢ÄÐÐÔ¸üÈÝÒ׸ÐȾйڷÎÑײ¢·¢Õ¹ÎªÖØÖ¢¡£µ«ÊÇ£¬µ½Ä¿Ç°ÎªÖ¹£¬»¹Ã»ÓÐÉúÎï±êÖ¾Îï¿ÉÒÔÔ¤²â¸öÌå¶ÔCOVID-19µÄÃô¸ÐÐÔ¡£ÄÏ·½¿Æ¼¼´óѧ¡¢ÉϺ£½»´ó¡¢Î人ÖÐÄÏÒ½Ôº¡¢Î人½ðÒø̶ҽԺµÈ8¼Òµ¥Î»µÄ×îÐÂÑо¿ÏÔʾ£ºA¡¢B¡¢O¡¢ABѪÐÍÓëйڷÎÑ×Ò׸ÐÐÔ´æÔÚ¹ØÁª¡£ÕâÒ²ÊǸÃÁìÓòµÄÊ×·ÝÑо¿¡£


    ¾ßÌåÀ´Ëµ£¬OÐÍѪ¶ÔйڷÎÑ×Ïà¶Ô²»Ò׸У¬·çÏսϵͣ»AÐÍѪ¶ÔйڷÎÑ×Ïà¶ÔÒ׸У¬·çÏÕÒ²½Ï¸ß¡£¸ÃÑо¿Ìáʾ£º£¨1£©AÐÍѪ¿ÉÄÜÐèÒªÌرð¼ÓÇ¿¸öÈ˱£»¤ÒÔ¼õÉÙ¸ÐȾ»ú»á£»£¨2£©Ð¹ڲ¡¶¾¸ÐȾµÄAÐÍѪ»¼Õß¿ÉÄÜÐèÒª½ÓÊܸü¶àµÄ¼à»¤ºÍÖÎÁÆ£»£¨3£©×÷Ϊйڲ¡¶¾ÖÎÁƵij£¹æ²¿·Ö£¬ÔÚ»¼ÕߺÍÒ½ÎñÈËÔ±ÖÐÒýÈëABOѪÐÍ¿ÉÄÜ»á°ïÖúÆÀ¹ÀÈËÃǵķçÏÕ±©Â¶Ë®Æ½¡£


    ¸ÃÑо¿À´×ÔÂÛÎÄ¡°Relationship between the ABO Blood Group and the COVID-19 Susceptibility¡±¡£¸ÃÂÛÎÄÓÚµ±µØʱ¼ä3ÔÂ17ÈÕ¿¯·¢ÔÚÔ¤Ó¡±¾Æ½Ì¨medRxiv£¬ÉÐδ¾­Í¬ÐÐÆÀÒé¡£


    ¸ÃÑо¿µÄÑù±¾À´×ÔÎ人ºÍÉîÛÚµÄÈý¼ÒÈý¼×Ò½Ôº£¬·Ö±ðÊÇ£ºÎ人ÊнðÒø̶ҽԺµÄ1775ÀýCOVID-19»¼Õߣ¬ÆäÖÐ206ÀýËÀÍö£»Î人´óѧÈËÃñÒ½ÔºµÄ113Ãû»¼Õߣ»ÉîÛÚÊеÚÈýÈËÃñÒ½ÔºµÄ285Ãû»¼Õß¡£Ñо¿ÈËÔ±Ö÷Òª¼ì²âÕâЩ»¼ÕßµÄABOѪÐÍ£¬Ð¹ڷÎÑ׵ĸÐȾ·¢ÉúÇé¿öÒÔ¼°ËÀÍöÇé¿ö¡£Í³¼Æ·ÖÎö²ÉÓõķ½·¨Êǵ¥ÒòËØ·½²î·ÖÎö £¨one-way ANOVA£©ºÍ˫⣨2-tailed£©¿¨·½¼ìÑé¡£Ñо¿»¹ÉèÖÃÁËËæ»úЧӦģÐÍ£¨REM£©£¬¶Ô²»Í¬Ò½ÔºµÄÊý¾Ý½øÐÐMeta·ÖÎö¡£


    Ñо¿ÏÔʾ£¬ÔÚÎ人ÊÐ3694ÃûÕý³£ÈËÖУ¬ A¡¢B¡¢ABºÍOÐÍѪµÄÕ¼±È·Ö±ðΪ32.16%¡¢24.90%¡¢9.10%ºÍ33.84%¡£¶øÔÚÎ人ÊнðÒø̶ҽԺµÄ1775ÃûCOVID-19»¼ÕßÖУ¬A¡¢B¡¢ABºÍOµÄÕ¼±È37.75%£¬26.42%£¬10.03%ºÍ25.80%¡£ÖµµÃ×¢ÒâµÄÊÇ£¬COVID-19»¼ÕßÖÐѪÐÍA±ÈÀýºÍOµÄ±ÈÀý·Ö±ðÏÔÖø¸ßÓں͵ÍÓÚÕý³£È˱ÈÀý£¨P <0.001£©¡£


    Î人´óѧÈËÃñÒ½ÔººÍÉîÛÚÊеÚÈýÈËÃñÒ½ÔºÕâÁ½¼ÒÈý¼×Ò½ÔºµÄ398Ãû»¼ÕßÒ²¹Û²ìµ½ÁËÏàËƵÄABO·Ö²¼Ä£Ê½¡£·ÖÎö½á¹ûÏÔʾ£¬ÓëO¡¢B¡¢ABѪÐÍÏà±È£¬AѪÐ͵ÄCOVID-19¸ÐȾ·çÏÕÏÔÖøÉý¸ß£¨ORΪ1.20£»95%ÖÃÐÅÇø¼äCIΪ1.02-1.43£¬P=0.02£©¡£ÓëA¡¢B¡¢ABѪÐÍÏà±È£¬OÐÍѪÐ͵Ĵ«È¾²¡·çÏÕÏÔÖø½µµÍ£¨ORΪ0.67£»95%CIΪ0.60-0.75£¬P <0.001£©¡£Ò²¾ÍÊÇ˵£¬Óë·ÇAѪÐÍÏà±È£¬¾ßÓÐAѪÐ͵ÄÈË»ñµÃCOVID-19µÄ·çÏÕÃ÷ÏÔ¸ü¸ß£¬¶øÓëOѪÐÍÏà±È£¬OѪÐ͵ĸÐȾ·çÏÕÏÔÖø½µµÍ¡£


    ´ËÇ°Ò²ÓÐһЩÑо¿ÏÔʾ£¬Ò»Ð©²¡¶¾¸ÐȾµÄÒ׸ÐÐÔÓëABOѪÐÍÓйء£ÀýÈ磬ŵÎֿ˲¡¶¾ºÍÒÒÐ͸ÎÑ×¾ßÓÐÃ÷È·µÄѪÐÍÒ׸ÐÐÔ¡£¶ø¾Ý´ËÇ°±¨µÀ£¬OÐÍѪµÄ¸öÌå¸ÐȾSARS¹Ú×´²¡¶¾µÄ¿ÉÄÜÐÔÒ²½ÏС¡£


    ¸ÃÂÛÎÄÓÐ8¼Ò¿ÆÑлú¹¹£¬·Ö±ðÊÇ£ºÄÏ·½¿Æ¼¼´óѧ¡¢ÉîÛÚÊеÚÈýÈËÃñÒ½Ôº£¨ÄÏ·½¿Æ¼¼´óѧµÚ¶þ¸½ÊôÒ½Ôº£©¡¢Î人ÊнðÒø̶ҽԺ¡¢Î人´óѧÈËÃñÒ½Ôº¡¢Öйúҽѧ¿ÆѧԺ¸·ÍâÒ½Ôº¡¢»ª¶«Ê¦·¶´óѧ¡¢Î人´óѧÖÐÄÏÒ½Ôº¡¢ÉϺ£½»Í¨´óѧ¡£Í¨Ñ¶×÷ÕßΪÄÏ·½¿Æ¼¼´óѧҽѧԺÊ×ÈÎÔº³¤¡¢½²Ï¯½ÌÊÚÐÏÃ÷ÕÕ£»ÄÏ·½¿Æ¼¼´óѧҽѧԺ¿ÆÑа칫ÊÒÖ÷ÈΡ¢½²Ï¯½ÌÊÚÍõÅô£»ÉϺ£½»Í¨´óѧÉúÃü¿Æѧ¼¼ÊõѧԺÑо¿Ô±Ñî¹ãÓÎ人´óѧÖÐÄÏÒ½ÔºÔº³¤¡¢À×ÉñɽҽԺԺ³¤ÍõÐл·µÈ¡£


    ¸½£ºÊý¾Ý·ÖÎö²¿·Ö


    Î人ÊÐ3694ÃûÕý³£È˵ÄABOѪÐÍ·Ö±ðÏÔʾA¡¢B¡¢ABºÍOÐÍѪÐ͵İٷֱȷֲ¼·Ö±ðΪ32.16%¡¢24.90%¡¢9.10%ºÍ33.84%£¬¶øÎ人ÊнðÒø̶ҽԺµÄ1775ÃûCOVID-19»¼ÕßÏÔʾA¡¢B¡¢ABºÍOÐÍѪÐ͵ÄABO·Ö²¼·Ö±ðΪ37.75%¡¢26.42%¡¢10.03%ºÍ25.80%¡£


    COVID-19»¼ÕßÖÐAÐÍѪµÄ±ÈÀýÏÔÖø¸ßÓÚÕý³£ÈËȺ£¬Ç°ÕßΪ37.75%£¬ºóÕßΪ32.16%£¨P <0.001£©¡£COVID-19»¼ÕßµÄOÐÍѪ±ÈÀýÏÔÖøµÍÓÚÕý³£ÈËȺ£¬Ç°ÕßΪ25.80%£¬ºóÕßΪ33.84%£¨P <0.001£©¡£


    ÔÚËÀÍö»¼ÕßÖй۲쵽¸ßΣѪÐÍAºÍµÍΣѪÐÍOµÄ·Ö²¼Ä£Ê½Ò²ÓëÖ®ÏàËÆ¡£¾ßÌå¶øÑÔ£¬ÔÚ206ÀýËÀÍö»¼ÕßÖУ¬A¡¢B¡¢ABºÍOѪÐ͵ıÈÀý·Ö±ðΪ41.26%¡¢24.27%¡¢9.22%ºÍ25.24%¡£Óë·ÇOÐÍѪ×éÏà±È£¬OÐÍѪËÀÍö·çÏÕ¸üµÍ£¬ORΪ0.660£¨95%CI 0.479-0.911£¬P=0.014£©¡£Ïà·´£¬Óë·ÇA×éÏà±È£¬A×éµÄËÀÍö·çÏÕ¸ü¸ß£¬ORΪ1.482£¨95%CI 1.113-1.972£¬P=0.008£©¡£


    ½ÓÏÂÀ´£¬Ñо¿ÍŶӼì²éÁËÎ人ÊÐÁíÒ»Ò½ÔºÎ人´óѧÈËÃñÒ½ÔºµÄ113ÀýCOVID-19»¼Õߣ¬·¢ÏÖÁËABOѪÐ͸ÐȾµÄÏàËÆ·çÏÕ·Ö²¼Ç÷ÊÆ¡£¾ßÌå¶øÑÔ£¬Óë·ÇOÐÍѪ×éÏà±È£¬OÐÍѪ×éÓë¸ÐȾ·çÏÕÏÔÖø½µµÍ£¬ORΪ0.644£¨95%CI 0.418-0.993£¬P=0.045£©¡£Óë·ÇAѪÐÍÏà±È£¬AѪÐ͵ÄÏà¶ÔΣÏնȸü¸ß£¨OR=1.396£» 95%CI 0.952-2.048£©£¬±ÈÎ人ÊнðÒø̶ҽԺµÄ»¼Õß»¹Òª¸ß£¬¾¡¹ÜÓÉÓÚÑù±¾Á¿Ïà¶Ô½ÏС£¬¸Ã×éÏà¹ØÐÔûÓÐͳ¼ÆѧÒâÒå¡£


    ÉîÛÚ23368ÃûÕý³£È˵ÄABOѪÐÍ·Ö±ðÏÔʾA¡¢B¡¢ABºÍOѪÐ͵İٷֱȷֲ¼·Ö±ðΪ28.77%¡¢25.14%¡¢7.32%ºÍ38.77%¡£¶ÔÉîÛÚµÄ285ÀýCOVID-19»¼ÕߵķÖÎöÏÔʾ£¬A¡¢B¡¢ABºÍOѪÐ͵ıÈÀý·Ö±ðΪ28.77%¡¢29.12%¡¢13.68%ºÍ28.42%¡£


    ͬÑù£¬OÐÍѪµÄ¸ÐȾ·çÏÕÏÔ׎µµÍ£¨ORΪ0.627£» 95%CIΪ0.484-0.812£©¡£´ËÍ⣬Ñо¿·¢ÏÖABѪÐ͵ĸÐȾ·çÏÕÔö¼Ó£¨ORΪ2.008£» 95%CIΪ1.427-2.824£©¡£ÁíÍ⣬Õâ285Ãû»¼ÕßµÄƽ¾ùÄêÁäΪ45.1¡À18.6Ë꣬ÆäÖаüÀ¨147ÃûÄÐÐÔºÍ138ÃûÅ®ÐÔ¡£Ñо¿·¢ÏÖ²»Í¬ABO×éµÄ»¼ÕßÄêÁäÎÞÏÔ×ŲîÒ죨F = 0.135£» P = 0.939£©¡£


    ͨ¹ýËæ»úЧӦģÐÍÏÔʾÁËÀ´×ÔÈý¼ÒÒ½ÔºµÄ»ã×ÜÊý¾Ý¶ÔABOѪÐ͵ÄCOVID-19·çÏÕµÄOR¹À¼ÆÖµ¡£½á¹ûÔٴαíÃ÷£¬Óë·ÇAÐÍѪÐÍÏà±È£¬AÐÍѪÐÍÓëCOVID-19µÄ·çÏÕÏÔÖøÉý¸ß£¨ORΪ1.21£» 95%CI 1.02-1.43£¬P = 0.027£©¡£Óë·ÇOÐÍѪÐÍÏà±È£¬¸ÐȾ·çÏÕÏÔÖø½µµÍ£¨OR£¬0.67£» 95%CI 0.60-0.75£¬P <0.001£©ÑªÐÍ¡£ÓëÆäËûABOѪÐÍÏà±È£¬ABѪÐÍ£¨OR£¬1.48£¬95%CI 0.97-2.24£©ºÍBѪÐÍ£¨OR£¬1.09£¬95%CI 0.98-1.22£©ËƺõÒ²¾ßÓиü¸ßµÄ¸ÐȾ·çÏÕ¡£²»¹ýÒÔÉÏÏà¹ØÐÔûÓдﵽͳ¼ÆѧÒâÒå¡£


    ½ÓÏÂÀ´£¬Ñо¿ÍŶӵ÷²éÁËÄêÁäºÍÐÔ±ðÕâÁ½¸öΣÏÕÒòËØÊÇ·ñ»áÓ°ÏìCOVID-19»¼ÕßÖÐABOѪÐ͵ķֲ¼¡£ÒÑÖªABOѪÐÍ·Ö²¼Ã»ÓÐÐÔ±ðºÍÄêÁäÆ«Ïò¡£ÀýÈ磬ͨ¹ý·ÖÎö³¬¹ý9ÍòÃûÕý³£È˵ÄѪÐÍ£¬¿ÉÒÔ¿´³ö²»Í¬ÄêÁä¶ÎºÍÐÔ±ðÖ®¼äµÄA¡¢B¡¢ABºÍOѪÐͰٷֱȻù±¾Ïàͬ¡£


    Òò´Ë£¬Ñо¿ÕßÒÔÎ人µØÇø3694ÃûÕý³£È˵ÄABOѪÐÍ·Ö²¼×÷Ϊ¶ÔÕÕ£¬ÒÔÓ벻ͬÄêÁä×éºÍÐÔ±ð×é½øÐбȽϡ£½«Î人ÊнðÒø̶ҽԺºÍÎ人ÈËÃñÒ½ÔºµÄËùÓл¼Õߺϲ¢ÔÚÒ»Æ𣨹²1888Ãû»¼Õߣ©£¬²¢·ÖΪÈý¸öÄêÁä×飨40ËêÒÔÏ£¬41-59Ë꣬60ËêÒÔÉÏ£©£¬ABOѪÐÍ·Ö²¼ÔÚ¸÷ÄêÁä×éÖ®¼äûÓб仯¡£Í¬Ñù£¬µ±·Ö±ð¿¼ÂÇCOVID-19»¼ÕßµÄÄÐŮʱ£¬ABOѪÐÍ·Ö²¼Ò²Ã»ÓÐÌ«´ó±ä»¯¡£


    ÌÖÂÛ


    ÕâÏîÑо¿·¢ÏÖABOѪÐͶÔйڲ¡¶¾¸ÐȾ±íÏÖ³ö²»Í¬µÄ¹ØÁª·çÏÕ¡£¾ßÌå¶øÑÔ£¬ÑªÐÍAÓë·çÏÕÔö¼ÓÓÐÏà¹ØÐÔ£¬¶øѪÐÍOÓë·çÏÕ½µµÍÓÐÏà¹ØÐÔ£¬Òò´ËÖ¤Ã÷ABOѪÐÍÊÇCOVID-19Ãô¸ÐÐÔ²îÒìµÄÉúÎï±êÖ¾Îï¡£


    ÕâЩ·¢ÏÖÓëÏÈÇ°Ñо¿Öз¢ÏÖµÄABOѪÐÍÏàËƵÄÆäËû¹Ú×´²¡¶¾¸ÐȾ·çÏÕģʽһÖ¡£±ÈÈ磬´ËÇ°ÓÐÑо¿ÏÔʾÏã¸ÛµÄSARS-CoV¸ÐȾÒ׸ÐÐÔÓëABOѪÐÍÓйء£


    Ñо¿Õß»¹·¢ÏÖ£¬Óë·ÇOÐÍѪÐÍÒ½Ôº¹¤×÷ÈËÔ±Ïà±È£¬OÐÍѪÐÍÒ½Ôº¹¤×÷ÈËÔ±±»¸ÐȾµÄ»ú»á¸üµÍ¡£´ËÇ°Óз¢ÏÖ¿¹A¿¹ÌåÌØÒìÐÔÒÖÖÆSARS-CoV Sµ°°×±í´ïϸ°ûÓëACE2±í´ïϸ°ûϵµÄÕ³¸½¡£¼øÓÚSARS-CoVºÍSARS-CoV-2Ö®¼äµÄºËËáÐòÁÐÏàËÆÐÔºÍÊÜÌåѪ¹Ü½ôÕÅËØת»»Ã¸2£¨ACE2£©½áºÏÏàËÆÐÔ£¬OÐÍѪÃô¸ÐÐԽϵͣ¬¶øAÐÍѪ¶ÔCOVID-19µÄÃô¸ÐÐԽϸߣ¬ÕâÓëѪҺÖÐÌìÈ»¿¹ÑªÐÍ¿¹Ì壬ÌرðÊÇ¿¹A¿¹ÌåµÄ´æÔÚÓйء£


    Ñо¿Í¬Ê±Ìáµ½£¬Õâ¸ö¼ÙÉ轫ÐèÒªÖ±½ÓÑо¿À´Ö¤Ã÷¡£ABOѪÐͶÔCOVID-19µÄÒ׸ÐÐÔ¿ÉÄÜ»¹´æÔÚÆäËû»úÖÆ£¬ÐèÒª½øÒ»²½Ñо¿¼ÓÒÔ²ûÃ÷¡££¨À´Ô´£ºÅìÅÈÐÂÎÅ£©


0 ÔĶÁ 0评论

推荐

  • QQ空间

  • 新浪微博

  • 人人网

  • 豆瓣

È¡Ïû
½¨Õ¾ABC ½¨Õ¾ABCÌṩ¼¼ÊõÖ§³Ö